Testing effectiveness (Phase 2)Study completedNCT02505269
What this trial is testing
Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Showing 20 of 51 results